Abstract: The present invention relates generally to antibodies that bind to the Interleukin-13 receptor ?1 chain (IL-13R?1) and antagonize IL-13 receptor-mediated signaling by IL-13 and/or IL-4. More particularly, the present invention provides humanized or human antibodies to mammalian and in particular IL-13R?1. These antibodies have uses in the treatment or prevention of IL-13- and/or IL-4-mediated diseases or conditions. The present invention further contemplates a method of modulating IL-13- and/or IL-4-mediated diseases or conditions by the administration of the subject antibodies. The present invention further provides an assay system useful for identifying antibodies or other agents which modulate IL-13 and/or IL-4 signaling through an IL-13 receptor complex. Accordingly, a method of screening for modulators of IL-13R?1/ligand interaction is also provided.

Abstract: A direct retinal display (50) for displaying an image on the retina of an eye (62) with a wide field of view. The direct retinal display (50) comprises a scan source (52) that is arranged to generate a scanned optical beam (58), modulated with an image, in two dimensions over a scan angle. The direct retinal display (50) further comprises a diverging reflector (54) in the path of the scanned optical beam (58) that is arranged to reflect the scanned optical beam (58) incident on the diverging reflector (54) outwardly with a magnified scan angle toward a converging reflector (56) that is arranged to reflect the scanned optical beam substantially toward a convergence spot at the pupil (60) of the eye (62) for reconstruction and display of the image on the retina with a wide field of view.

Abstract: The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject invention is directed to recombinant or synthetic haemopoietin receptors or components or parts thereof. The receptor molecules or components or parts thereof and their genetic sequences of the present invention are useful in the development of a wide range agonists, antagonists and therapeutics and diagnostic reagents based on ligand interaction with its receptor.

Abstract: A fire extinguisher comprising a deployable flexible frame and a fire resistant material mounted to the flexible frame for being applied on a fire for extinguishment thereof. A fire extinguisher kit comprising the foregoing material that is mountable to the foregoing frame. The fire resistant material can be in the form of a towel that is mounted to the frame. Upon discovery of a fire, the fire extinguisher can be pulled out of its container and can immediately deploy, a handle allows the user to place the fire extinguisher over the burning object such as a pan, an additional material may hang from the frame to securely surround the object. When not in use the fire extinguisher may be foldably inserted into its container.

Abstract: The present invention relates to the use of leukemia inhibitory factor (LIF) in the isolation and propagation of embryonic stem cells in vitro.

Abstract: The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject invention is directed to recombinant or synthetic haemopoietin receptors or components or parts thereof. The receptor molecules or components or parts thereof and their genetic sequences of the present invention are useful in the development of a wide range of agonists, antagonists and therapeutics and diagnostic reagents based on ligand interaction with its receptor.

Abstract: The present invention is directed to a novel haemopoietin receptor or a derivative thereof and to genetic sequences encoding same. The receptor molecule and its derivatives and the genetic sequences encoding same of the present invention are useful in the development of a wide range of agonists, antagonists, therapeutics and diagnostic reagents based on ligand interaction with its receptor. The present invention particularly relates to a receptor for leptin.

Abstract: A RF power measurement circuit for measuring RF power of a pulsed RF input signal has a sigma-delta ADC circuit and an AND gate for controlling delivery of clock pules to a clock input of the ADC circuit. The clock pulses are delivered to the clock input only within the duration of RF pulses of the pulsed RF input signal enabling a low speed ADC circuit to be used.

Abstract: The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject invention is directed to recombinant or synthetic haemopoietin receptors or components or parts thereof. The receptor molecules or components or parts thereof and their genetic sequences of the present invention are useful in the development of a wide range of agonists, antagonists and therapeutics and diagnostic reagents based on ligand interaction with its receptor.

Abstract: The present invention relates to the use of leukaemia inhibitory factor (LIF) in the isolation and propagation of embryonic stem cells in vitro.

Abstract: The present invention relates to the use of leukemia inhibitory factor (LIF) in the isolation and propagation of embryonic stem cells in vitro.

Abstract: The present invention relates to the use of leukaemia inhibitory factor (LIF) in the isolation and propagation of embryonic stem cells in vitro.

Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.

Abstract: The present invention is directed to a novel haemopoietin receptor or a derivative thereof and to genetic sequences encoding same. The receptor molecule and its derivatives and the genetic sequences encoding same of the present invention are useful in the development of a wide range of agonists, antagonists, therapeutics and diagnostic reagents based on ligand interaction with its receptor. The present invention particularly relates to a receptor for leptin.

Abstract: The present invention relates generally to novel haemopoietin receptors, or components or parts thereof and to a method for cloning genetic sequences encoding same. More particularly, the subject invention is directed to recombinant or synthetic haemopoietin receptors or components or parts thereof. The receptor molecules or components or parts thereof and their genetic sequences of the present invention are useful in the development of a wide range of agonists, antagonists and therapeutics and diagnostic reagents based on ligand interaction with its receptor.

Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF and methods of producing LIF by the expression of the isolated DNA and suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.

Abstract: The present invention provides isolated DNA molecules encoding human and murine LIF, and methods of producing LIF by the expression of the isolated DNA in suitable host cells. The invention further provides human and murine LIF polypeptides, pharmaceutical compositions containing LIF, and methods of use thereof.

Abstract: The fireplace screen comprises a frame defining a central opening and including first and second pairs of vertical guide tracks along opposite lateral sides of the opening. A housing is mounted above the frame and a first flexible covering element is mounted for movement in the first pair of guide tracks. The first flexible covering element comprises a perforate mesh formed of heat resistant material. A second flexible covering element is mounted for movement in the second pair of guide tracks. The second covering element comprises an imperforate heat resistant material. A mechanism is mounted in the housing for individually raising and lowering the first and second covering elements in the guide tracks thereby covering and uncovering the central opening.

Abstract: An electrode for an arc discharge lamp includes a porous sintered body of tungsten impregnated with a mixture of alkaline earth oxides and a metal oxide. The alkaline earth materials may be oxides of barium and calcium, and the metal oxide may be aluminum oxide. The body is brazed or welded to the end of a high melting point refractory metal support of tungsten or molybdenum. Two identical electrodes are used as the cathodes of a long arc alternating current type xenon lamp and one such electrode provides the cathode of a short arc direct current xenon lamp. The structure and materials provide greater efficiency and extended life under continuous operating conditions.